StockWatch
·
Biotechnology: Pharmaceutical Preparations
DelistingJul 10, 2026, 04:08 PM

GeoVax Labs Receives Nasdaq Delisting Notice for Equity Non-Compliance

AI Summary

GeoVax Labs, Inc. announced it received a notice from the Nasdaq Stock Market LLC on July 7, 2026, indicating non-compliance with the $2,500,000 minimum stockholders' equity requirement for continued listing. The company also did not meet alternative listing standards. GeoVax has until August 21, 2026, to submit a plan to regain compliance, and its common stock will continue to trade on Nasdaq under the symbol "GOVX" during this period.

Key Highlights

  • GeoVax Labs received a notice from Nasdaq on July 7, 2026.
  • The notice indicates non-compliance with Nasdaq Listing Rule 5550(b)(1).
  • The company failed to meet the $2,500,000 minimum stockholders' equity requirement.
  • GeoVax also did not meet alternative requirements for market value or net income.
  • The company has 45 calendar days, until August 21, 2026, to submit a compliance plan.
  • The notice has no immediate effect on the company's Nasdaq listing; stock continues to trade as GOVX.